Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
A Phase 2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
M05-780
NCT00297089
Last Modified:
4/18/2008
 
First Published:
5/4/2007
2.
Phase I/II Pilot Study of ABT-751 in Patients With Androgen-Independent, Hormone-Refractory Metastatic Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
NCI
VU-VICC-URO-0426
NCT00471718
3.
Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
Other
D0412
NCT00735878
4.
A Study of ABT-751 in Patients With Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
M02-446
NCT00073138
5.
A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
Pharmaceutical / Industry
M02-447
NCT00063102
Last Modified:
4/2/2004
 
First Published:
2/20/2004
6.
Phase II Study of ABT-751 in Patients With Locally Recurrent or Metastatic Renal Cell Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCLA-0308113
ABBOTT-M02-416, NCT00080717
Last Modified:
1/14/2005
 
First Published:
2/20/2004
7.
Phase II Study of ABT-751 in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Refractory to Taxane Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI, Pharmaceutical / Industry
UCLA-0308111
ABBOTT-M02-448, NCT00080730
Last Modified:
7/9/2008
 
First Published:
5/1/2002
8.
Phase I Study of 7-Day or 21-Day ABT-751 in Children With Refractory Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and under
NCI, Pharmaceutical / Industry
NCI-02-C-0141L
ABBOTT-M01-357, NCT00036959
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute